Vaccines

Page Contents

The page contains information about the recommended vaccines for the 2026/27 COVID and FLU campaigns as well as links to the Green Book and other useful resources

Seasonal Flu

Updates:

Amendment to national flu immunisation programme 2026 to 2027 letter – GOV.UK

National flu immunisation programme 2026 to 2027 letter – GOV.UK

JCVI statement on influenza vaccines for 2026 to 2027 – GOV.UK

Influenza: the green book, chapter 19 – GOV.UK

Influenza vaccines marketed in the UK – GOV.UK

Annual flu programme – GOV.UK

Key points:

Table 1: Recommended adult influenza vaccines that will be reimbursed

Vaccines that are currently listed here as quadrivalent (Q) formulations are likely to be supplied as trivalent (T) ones (and therefore both formulations are listed in the tables).

Order any first line vaccine ahead of second line:

Aged 18 to 49 years in clinical risk group (including pregnant women)	Aged 50 to 64 years (in a clinical risk group)	Aged 65 years and over
All vaccines are listed alphabetically. Order any of these vaccines: • cell-cultured (IIVc) • or recombinant (IIVr)	All vaccines are listed alphabetically. Order any of these vaccines: • adjuvanted (aIIV) • or cell-cultured (IIVc) • or high dose (IIV-HD) (licensed from 60 years of age but can be given off label to those aged 50 to 59 years) • or recombinant (IIVr)	All vaccines are listed alphabetically. Order any of these vaccines: • adjuvanted (aIIV) • or cell-cultured (IIVc) • or high dose (IIV-HD) • or recombinant (IIVr)

Aged 18 to 49 years in clinical risk group (including pregnant women)

Aged 50 to 64 years (in a clinical risk group)

Aged 65 years and over

All vaccines are listed alphabetically.

Order any of these vaccines:

• cell-cultured (IIVc)
• or recombinant (IIVr)

All vaccines are listed alphabetically.

Order any of these vaccines:

• adjuvanted (aIIV)
• or cell-cultured (IIVc)
• or high dose (IIV-HD) (licensed from 60 years of age but can be given off label to those aged 50 to 59 years)
• or recombinant (IIVr)

All vaccines are listed alphabetically.

Order any of these vaccines:

• adjuvanted (aIIV)
• or cell-cultured (IIVc)
• or high dose (IIV-HD)
• or recombinant (IIVr)

The RSV vaccine should not routinely be scheduled to be given to an older adult at the same appointment as a flu vaccine as some data indicates that this may reduce the immune response to the flu and RSV vaccines. No specific interval is required between administering the vaccines. If it is thought that the individual is unlikely to return for a second appointment or immediate protection is necessary, then the RSV can be administered at the same time as flu.

Children’s vaccines

No changes were recommended by JCVI for children’s flu vaccines for 2026 to 2027.

Table 2: Recommended flu vaccines for children

Children aged 6 months to less than 2 years in clinical risk groups	Children aged 2 to less than 18 years in eligible groups (including clinical risk groups)
Offer in the following order of preference: 1. IIVc 2. IIVe	Offer in the following order of preference: 1. LAIV (live attenuated inactivated influenza vaccine) 2. IIVc is recommended where LAIV is contraindicated or otherwise unsuitable (for example, parents object to LAIV on the grounds of its porcine gelatine content) 3. IIVe

Children aged 6 months to less than 2 years in clinical risk groups

Children aged 2 to less than 18 years in eligible groups (including clinical risk groups)

Offer in the following order of preference:

1. IIVc
2. IIVe

Offer in the following order of preference:

1. LAIV (live attenuated inactivated influenza vaccine)
2. IIVc is recommended where LAIV is contraindicated or otherwise unsuitable (for example, parents object to LAIV on the grounds of its porcine gelatine content)
3. IIVe

Back to Top